Aims and Scope
European Cardiology Review (ECR) is an international, English language, open-access, peer-reviewed journal that is published three times a year and aims to assist time-pressured physicians to stay abreast of key advances and opinion in the area of cardiovascular medicine.
The journal comprises balanced and comprehensive review articles written by leading authorities. The journal provides updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice.
The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.
Led by Editor-in-Chief, Juan Carlos Kaski, along with Associate Editor, Pablo Avanzas and an editorial board of world-renowned physicians, the Journal publishes peer-reviewed articles that aim to provide timely updates on the most pertinent issues in the field.
For information on submitting an article, please contact Ashlynne Merrifield, Managing Editor, email@example.com.
Frequency: Three print issues per year; ePub ahead of print throughout the year.
Print ISSN: 1758-3756 Online ISSN: 1758-3764
Abstracting and Indexing: The Journal is abstracted, indexed and listed in PubMed, PubMed Central, Crossref, Emerging Sources Citation Index (ESCI), Scopus, SIS and the International Scientific Index (ISI). All articles are published in full on PubMed Central one month after publication.
Distribution and Readership
The Journals are distributed through controlled circulation to general and specialist senior cardiovascular professionals in Europe. They are free to view online in HTML and are available for download in PDF format to registered users. Print subscriptions are available upon request.
Structure and Format
The journal consists of review articles, editorials, expert opinions and on occasion, letters to the editor.
The Journal is guided by the Editor-in-Chief, supported by an Associate Editor and an Editorial Board who are all recognised experts in their fields.
All submissions are subject to initial appraisal by the Editor in Chief, and, if found suitable for further consideration, sent forward for peer review by independent, anonymous expert referees. All peer review is double blind and submission is online via Editorial Manager.
ECR has an official partnership with the International Society of Cardiovascular Pharmacotherapy (ISCP).
ECR Journal is a member of CrossRef and STM.
On submission, all articles are assessed by the Editor-in-Chief or Managing Editor to determine their suitability for inclusion.
The Managing Editor, following consultation with the Editor-in-Chief, Section Editors and/or a member of the Editorial Board, sends the manuscript to members of the Peer Review Board, who are selected on the basis of their specialist knowledge in the relevant area. All peer review is conducted double-blind.
Following review, manuscripts are either accepted without modification or accepted pending modification, in which case the manuscripts are returned to the author(s) to incorporate required changes, or rejected outright. The Editor-in-Chief reserves the right to accept or reject any proposed amendments.
Once the authors have amended a manuscript in accordance with the reviewers’ comments, the manuscript is returned to the reviewers to ensure the revised version meets their quality expectations. Once approved, the manuscript is sent to the Editor-in-Chief for final approval prior to publication.
Our funding model, Open Access and APCs
Radcliffe Cardiology provides free educational content to cardiologists and allied healthcare professionals via our gold open access publishing model.
To support open access publication costs, Radcliffe Cardiology and Radcliffe Vascular charge an Article Publication Charge (APC) to authors upon acceptance of an unsolicited paper. More details on these charges, waiver policy and open access licensing can be found in the Information for Authors section.
The vast majority of our content is editorially independent, developed at our own cost. However, we do collaborate and receive funding from select industry partners in the following ways; all sources of such funding are fully declared on all these materials:
- Print and ebook adverts at the front and back of the journals (never within the journal text)
- Web banner advertising
- Interstitial adverts
- Pre-roll video adverts (as pre-cursors to our independent content)
- Promotional/supplemental content (published as supplements to our peer-reviewed journals)
- Supported webinars, roundtable discussions, video interviews and live cases
- Continuing medical education (CME) activities
We invite authors wishing to discuss potential submission to contact the Journal’s Managing Editor, firstname.lastname@example.org for further details or review the Author Guidelines..
We invite contributions from leading authorities who are identified by the Editor-in-Chief and/or with the support of the Section Editors and guidance from the Editorial Board. Following acceptance of an invitation, the authors and Managing Editor, in conjunction with the Editor-in-Chief, formalise the working title and scope of the article. The Managing Editor will provide further information and submission instructions.
We welcome unsolicited contributions which are assessed by the Editor-in-Chief for suitability and relevance prior to peer review.
The journal follows the International Committee of Medical Journals (ICMJE) guidance and to the Committee on Publication Ethics (COPES). We expect all parties involved in the journal publication to follow these guidelines to their best endeavours.
All articles published in ECR are available as reprints (minimum order 1,000). Please contact Rob Barclay at email@example.com